Patient Capital Management, LLC
Patient Capital Management, LLC reported 41 positions worth $2.98B as of September 30, 2026 (13F filed November 12, 2026). Largest holding: RPRX (6.3%). Biggest move: new buy META PLATFORMS INC ($124.4M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | RPRX | $199.7M | 6.35% | 3,422,067 | — | — | +17.4% | |
| ▸ 2 | C | $179.9M | 5.72% | 1,389,556 | — | — | -6.3% | |
| ▸ 3 | GOOGL | $178.4M | 5.67% | 518,480 | — | — | -17.5% | |
| ▸ 4 | AMZN | $168.7M | 5.36% | 677,117 | — | — | +3.5% | |
| ▸ 5 | NVDA | $162.1M | 5.15% | 709,927 | — | — | -31.6% | |
| ▸ 6 | UNH | $156.3M | 4.97% | 425,852 | — | — | +12.2% | |
| ▸ 7 | PGEN | $153.7M | 4.88% | 17,950,104 | — | — | -47.0% | |
| ▸ 8 | META | $131.2M | 4.17% | 180,982 | — | — | -13.6% | |
| ▸ 9 | QXO | $127.8M | 4.06% | 10,932,468 | — | — | +2.7% | |
| ▸ 10 | CHYM | $126.0M | 4.01% | 4,730,900 | — | — | +28.7% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Patient Capital Management, LLC hold as of Q3 2026?
Patient Capital Management, LLC reported 41 positions worth $2.98B in its Q3 2026 13F filing. Largest positions: RPRX (6.3%), C (5.7%), GOOGL (5.7%), AMZN (5.4%) and NVDA (5.2%).
What did Patient Capital Management, LLC buy in Q3 2026?
New positions: META PLATFORMS INC, AVGO, IDRV and XHB. Added to: QXO, CHYM, ADBE, META and FBTC (6 in all).
What did Patient Capital Management, LLC sell in Q3 2026?
Reduced: JD, CVS, PPLI, DAL and FISV (27 in all). Sold out entirely: ILMN, PLAY and SPY.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.